Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy

Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy

US Patent 6506572 · Granted Jan 14, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

DNA-functionalized scaffolds for drug capture applications2020
Composition of a first non-labeled monoclonal antibody binding to a tumor antige2017
Metathesis depolymerization using acrylates2016
Combination therapy of anti-HER3 antibodies2015
Tumor therapy with an antibody for vascular endothelial growth factor and an ant2015
Composition of a first non-labeled monoclonal antibody binding to a tumor antige2013
Method for the production of N,N-dimethylacetamide (DMAC)2012
Method for the production of N,N-dimethylacetamide (DMAC)2012
Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors2010
Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors2009
Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytost2008
Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytost2008